APOE and cerebral small vessel disease: A previous study showed that the risk factors for the incidence of small cerebral vessel diseases including white matter hyperintensities, lacunes, and microbleeds that were strongly associated with dementia and cognitive impairment in subjects with APOE ε4 allele were markedly mitigated by rosuvastatin (Ji et al., 2018).